Sign Up Today and Learn More About Iktos Stock
Invest in or calculate the value of your shares in Iktos or other pre-IPO companies through EquityZen's platform.
Iktos Stock
Iktos is a deep learning technology platform focused on new drug design and discovery.
About Iktos Stock
Founded
2016
Industries
Iktos Press Mentions
Stay in the know about the latest news on Iktos
Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery
morningstar • Jul 08, 2024
Italfarmaco and Iktos collaborate to develop HDAC inhibitors for noncancer indications
bioworld • Jun 21, 2024
Iktos and Nerviano Medical Sciences Announce AI Collaboration
pharmaceuticalmanufacturer • Jun 05, 2024
Elsevier and Iktos Partner to Deliver an AI-Driven Synthetic Chemistry Platform for Drug Discovery
finance • May 23, 2024
Five AI drug discovery companies you should know about
labiotech • May 04, 2024
Iktos Management
Leadership team at Iktos
Chief AI Officer, Co-founder
Nicolas Do Huu
CEO & Co-Founder
Yann Gaston-Mathe
Join now and verify your accreditation status to gain access to:
- Iktos current valuation
- Iktos stock price
- Available deals in Iktos and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Iktos stock?
Accredited investors can buy pre-IPO stock in companies like Iktos through EquityZen funds. These investments are made available by existing Iktos shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Iktos stock?
Shareholders can sell their Iktos stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
